Lithium Dosage Titration
Begin lithium at 300 mg twice daily (or 450 mg twice daily if the patient is clinically stable and not elderly), then adjust the dose gradually based on serum levels checked 5 days after each dose change, targeting a therapeutic range of 0.8–1.2 mEq/L. 1
Initial Dosing Strategy
- Start with 300 mg twice daily as the standard initiation dose for most patients 1
- Use 450 mg twice daily as an alternative starting dose only in clinically stable, non-elderly patients 1
- The empirical titration method remains the time-honored standard approach in clinical practice, despite the existence of various predictive dosing methods that have shown inconsistent results 2
Timing of Dose Adjustments
- Wait approximately 5 days between dose changes to allow lithium to reach steady-state, given its elimination half-life of 18–36 hours 3
- Serum lithium levels should be drawn 12 hours after the last dose to accurately assess therapeutic range 4, 3
- Avoid rapid loading strategies in routine practice; while loading may achieve therapeutic levels faster, it is associated with significantly more adverse effects (51.2% vs 36.0% with titration) without demonstrable improvement in clinical outcomes 5
Target Therapeutic Range and Monitoring
- Aim for 0.8–1.2 mEq/L as the target therapeutic concentration during acute treatment 1
- Some guidelines support a maintenance range of 0.6–0.8 mEq/L, though 0.8–1.2 mEq/L is preferred for acute stabilization 3
- Check lithium levels every 3–6 months once a stable dose is achieved, along with renal function (BUN, creatinine) and thyroid function (TSH, free T4) 1, 6, 4
Critical Safety Considerations
- The therapeutic window is extremely narrow—therapeutic levels (0.6–1.2 mEq/L) are dangerously close to toxic levels (>1.5 mEq/L) 4, 7
- Baseline laboratory assessment is mandatory before initiating lithium: obtain CBC, thyroid function tests (TSH, free T4), urinalysis, BUN, creatinine, serum calcium, and pregnancy test if applicable 1, 6, 4
- Educate patients to watch for early toxicity symptoms (tremor, ataxia, confusion, diarrhea, vomiting, nausea) and to discontinue the drug immediately if they occur 4, 7
Common Pitfalls to Avoid
- Do not make dose adjustments without checking serum levels—clinical decision-making must be guided by laboratory monitoring, especially during titration 5
- Never abruptly discontinue lithium—sudden cessation carries relapse rates exceeding 80%, particularly within the first 6 months 4
- Avoid using predictive dosing methods (such as single-dose test methods); these have shown poor reliability, with failure rates of 30.7% or higher in achieving target therapeutic ranges 8
- Do not assume elderly patients require the same dosing—reduce initial doses to 15–20 mmol (550–740 mg) daily for patients over 60 years 3
Duration of Titration Phase
- Plan for 12–24 months of maintenance therapy after achieving mood stabilization before considering any dose reduction 1, 4
- Assess clinical stability weekly during the conversion or titration period to detect early signs of mood-episode relapse 1
- A therapeutic trial must last at least 6–8 weeks at adequate doses before concluding a medication is ineffective 6